Botanical species · safety record

Juniperus drupacea

The EFSA Compendium of Botanicals holds 14 constituent measurements for Juniperus drupacea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Juniperus drupacea Labill.

14Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Trunk	Solvent extraction	—	—	Resolve DOI
Camphor	Fruit unspecified	Essential oil	10.12 Percent	—	Resolve DOI
Coumarins	Trunk	Solvent extraction	—	—	Resolve DOI
Lignans	Trunk	Solvent extraction	—	—	Resolve DOI
Myrcene	Fruit unspecified	Essential oil	≥ 1.31 Percent	—	Resolve DOI
Myrcene	Fruit unspecified	Essential oil	≤ 4.52 Percent	—	Resolve DOI
Tannins	Trunk	Solvent extraction	≤ 128.23 Gram/kilogram	—	Resolve DOI
Tannins	Trunk	Solvent extraction	≥ 51.22 Gram/kilogram	—	Resolve DOI
1,8-cineole	Leaves	Essential oil	4.27 Percent	—	No resolvable identifier
Epigallocatechins	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Gallocatechin	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Myrcene	Leaves	Essential oil	3.53 Percent	—	No resolvable identifier
Neolignans	Trunk	Solvent extraction	≥ 0.2 Milligram/gram	—	No resolvable identifier
Neolignans	Trunk	Solvent extraction	≤ 7 Milligram/gram	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Marino, Andreana., Bellinghieri, Valentina., Nostro, Antonia., Miceli, Natalizia., Taviano, Maria Fernanda., Guvenc, Ayseguel., Bisignano, Giuseppe. In vitro effect of branch extracts of Juniperus species from Turkey on Staphylococcus aureus biofilm . Fems immunology and medical microbiology, 2010, vol. 59, no. 3, p. 470-476. DOI
Willfor, S., Hafizoglu, H., Tumen, I., Yazici, H., Arfan, M., Ali, M., Holmbom, B. Extractives of Turkish and Pakistani Tree Species. Holz als roh- und werkstoff, 2007, p. 215-221.
Jalal, F., Wassim, A., Issam, H.A.M. Chemical composition of essential oil extracted from Syrian juniper berries (Juniperus drupacea L.). International journal of agricultural research, 2014, vol. 9, no. 3, p. 158-163. DOI
El-Ghorab, Ahmed., Shaaban, Hamdy A., El-Massry, Khaled F., Shibamoto, Takayuki. Chemical composition of volatile extract and biological activities of volatile and less-volatile extracts of juniper berry (Juniperus drupacea L.) fruit . Journal of agricultural and food chemistry, 2008, vol. 56, no. 13, p. 5021-5025. DOI
Taviano, Maria Fernanda., Marino, Andreana., Trovato, Ada., Bellinghieri, Valentina., La Barbera, Tommaso Massimo., Guvenc, Aysegul., Hurkul, Muhammed Mesud., De Pasquale, Rita., Miceli, Natalizia. Antioxidant and antimicrobial activities of branches extracts of five Juniperus species from Turkey . Pharmaceutical biology, 2011, vol. 49, no. 10, p. 1014-1022. DOI
Sakar, M. K. Composition of the oil of Juniperus drupacea leaves. Fitoterapia, 1985, p. 360-361.
Sakar, M. Koray. Monomeric tannin precursors in unripe fruit of Juniperus drupacea. Fitoterapia, 1985, p. 119-121.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature